Both Pre-frailty and Frailty Increase Healthcare Utilization and Adverse Health Outcomes in Patients with Type 2 Diabetes Mellitus

Overview

Journal Cardiovasc Diabetol

Publisher Biomed Central

Specialties Cardiology & Vascular Diseases
Endocrinology

Date 2018 Sep 29

PMID 30261879

Citations 59

Authors

Chia-Ter Chao

Jui Wang

Kuo-Liong Chien

Affiliations

Soon will be listed here.

Abstract

Background: Diabetes mellitus (DM) correlates with accelerated aging and earlier appearance of geriatric phenotypes, including frailty. However, whether pre-frailty or frailty predicts greater healthcare utilization in diabetes patients is unclear.

Methods: From the Longitudinal Cohort of Diabetes Patients in Taiwan (n = 840,000) between 2004 and 2010, we identified 560,795 patients with incident type 2 DM, categorized into patients without frailty, or with 1, 2 (pre-frail) and ≥ 3 frailty components, based on FRAIL scale (Fatigue, Resistance, Ambulation, Illness, and body weight Loss). We examined their long-term mortality, cardiovascular risk, all-cause hospitalization, and intensive care unit (ICU) admission.

Results: Among all participants (56.4 ± 13.8 year-old, 46.1% female, and 84.8% community-dwelling), 77.8% (n = 436,521), 19.2% (n = 107,757), 2.7% (n = 15,101), and 0.3% (n = 1416) patients did not have or had 1, 2 (pre-frail), and ≥ 3 frailty components (frail), respectively, with Fatigue and Illness being the most common components. After 3.14 years of follow-up, 7.8% patients died, whereas 36.6% and 9.1% experienced hospitalization and ICU stay, respectively. Cox proportional hazard modeling discovered that patients with 1, 2 (pre-frail), and ≥ 3 frailty components (frail) had an increased risk of mortality (for 1, 2, and ≥ 3 components, hazard ratio [HR] 1.05, 1.13, and 1.25; 95% confidence interval [CI] 1.02-1.07, 1.08-1.17, and 1.15-1.36, respectively), cardiovascular events (HR 1.05, 1.15, and 1.13; 95% CI 1.02-1.07, 1.1-1.2, and 1.01-1.25, respectively), hospitalization (HR 1.06, 1.16, and 1.25; 95% CI 1.05-1.07, 1.14-1.19, and 1.18-1.33, respectively), and ICU admission (HR 1.05, 1.13, and 1.17; 95% CI 1.03-1.07, 1.08-1.14, and 1.06-1.28, respectively) compared to non-frail ones. Approximately 6-7% risk elevation in mortality and healthcare utilization was noted for every frailty component increase.

Conclusion: Pre-frailty and frailty increased the risk of mortality and cardiovascular events, and entailed greater healthcare utilization in patients with type 2 DM.

Citing Articles

Ketoanalogue use is associated with a lower risk of worsening frailty among patients with diabetic kidney disease of advanced stage: A retrospective cohort study.

Wang J, Lee S, Chao C, Huang J, Chien K Heliyon. 2024; 10(22):e40392.

PMID: 39641054 PMC: 11617760. DOI: 10.1016/j.heliyon.2024.e40392.

Impact of exercise training in combination with dapagliflozin on physical function in adults with type 2 diabetes mellitus: study protocol for the Dapagliflozin, Exercise Training and physicAl function (DETA) randomised controlled trial.

Sargeant J, Ahmad E, James E, Baker L, Bilak J, Coull N BMJ Open. 2024; 14(11):e084482.

PMID: 39592159 PMC: 11590848. DOI: 10.1136/bmjopen-2024-084482.

Prevalence and risk factors of frailty in older adults with diabetes: A systematic review and meta-analysis.

Liu Y, Zhang L, Li X, Luo A, Guo S, Liu X PLoS One. 2024; 19(10):e0309837.

PMID: 39480799 PMC: 11527323. DOI: 10.1371/journal.pone.0309837.

Trajectories and management of vascular risk following the diagnosis of multiple sclerosis: A population-based matched cohort study between 1987 and 2018 in England.

Palladino R, Chataway J, Mathew M, Majeed A, Marrie R Mult Scler. 2024; 30(13):1653-1663.

PMID: 39420581 PMC: 11568649. DOI: 10.1177/13524585241287388.

Frailty assessment and outcomes in primary care for patients with diabetes during Ramadan: implications for risk evaluation and care plans.

Baynouna Alketbi L, Afandi B, Nagelkerke N, Abdubaqi H, Al Nuaimi R, Al Saedi M Front Med (Lausanne). 2024; 11:1426140.

PMID: 39411191 PMC: 11475290. DOI: 10.3389/fmed.2024.1426140.

References

Wen Y, Chen L, Hsiao F . Predicting mortality and hospitalization of older adults by the multimorbidity frailty index. PLoS One. 2017; 12(11):e0187825. PMC: 5690585. DOI: 10.1371/journal.pone.0187825. View

Goedendorp M, Tack C, Steggink E, Bloot L, Bazelmans E, Knoop H . Chronic fatigue in type 1 diabetes: highly prevalent but not explained by hyperglycemia or glucose variability. Diabetes Care. 2013; 37(1):73-80. DOI: 10.2337/dc13-0515. View

Hajek A, Bock J, Saum K, Matschinger H, Brenner H, Holleczek B . Frailty and healthcare costs-longitudinal results of a prospective cohort study. Age Ageing. 2017; 47(2):233-241. DOI: 10.1093/ageing/afx157. View

Noh M, Kwon H, Jung C, Kwon S, Kim M, Lee W . Impact of diabetes duration and degree of carotid artery stenosis on major adverse cardiovascular events: a single-center, retrospective, observational cohort study. Cardiovasc Diabetol. 2017; 16(1):74. PMC: 5461631. DOI: 10.1186/s12933-017-0556-0. View

Comans T, Peel N, Hubbard R, Mulligan A, Gray L, Scuffham P . The increase in healthcare costs associated with frailty in older people discharged to a post-acute transition care program. Age Ageing. 2016; 45(2):317-20. DOI: 10.1093/ageing/afv196. View

Mohammedi K, Woodward M, Marre M, Colagiuri S, Cooper M, Harrap S . Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes. Cardiovasc Diabetol. 2017; 16(1):95. PMC: 5530952. DOI: 10.1186/s12933-017-0574-y. View

Faurot K, Funk M, Pate V, Brookhart M, Patrick A, Hanson L . Using claims data to predict dependency in activities of daily living as a proxy for frailty. Pharmacoepidemiol Drug Saf. 2014; 24(1):59-66. PMC: 4293227. DOI: 10.1002/pds.3719. View

Casanova F, Adingupu D, Adams F, Gooding K, Looker H, Aizawa K . The impact of cardiovascular co-morbidities and duration of diabetes on the association between microvascular function and glycaemic control. Cardiovasc Diabetol. 2017; 16(1):114. PMC: 5603035. DOI: 10.1186/s12933-017-0594-7. View

Chao C, Hsu Y, Chang P, He Y, Ueng R, Lai C . Simple self-report FRAIL scale might be more closely associated with dialysis complications than other frailty screening instruments in rural chronic dialysis patients. Nephrology (Carlton). 2015; 20(5):321-8. DOI: 10.1111/nep.12401. View

10.

Yanase T, Yanagita I, Muta K, Nawata H . Frailty in elderly diabetes patients. Endocr J. 2017; 65(1):1-11. DOI: 10.1507/endocrj.EJ17-0390. View

11.

Blodgett J, Theou O, Howlett S, Wu F, Rockwood K . A frailty index based on laboratory deficits in community-dwelling men predicted their risk of adverse health outcomes. Age Ageing. 2016; 45(4):463-8. DOI: 10.1093/ageing/afw054. View

12.

Rockwood K, Stadnyk K, Macknight C, McDowell I, Hebert R, Hogan D . A brief clinical instrument to classify frailty in elderly people. Lancet. 1999; 353(9148):205-6. DOI: 10.1016/S0140-6736(98)04402-X. View

13.

Cesari M, Costa N, Hoogendijk E, Vellas B, Canevelli M, Perez-Zepeda M . How the Frailty Index May Support the Allocation of Health Care Resources: An Example From the INCUR Study. J Am Med Dir Assoc. 2016; 17(5):448-50. DOI: 10.1016/j.jamda.2016.02.007. View

14.

Sinclair A, Abdelhafiz A, Rodriguez-Manas L . Frailty and sarcopenia - newly emerging and high impact complications of diabetes. J Diabetes Complications. 2017; 31(9):1465-1473. DOI: 10.1016/j.jdiacomp.2017.05.003. View

15.

Yu R, Morley J, Kwok T, Leung J, Cheung O, Woo J . The Effects of Combinations of Cognitive Impairment and Pre-frailty on Adverse Outcomes from a Prospective Community-Based Cohort Study of Older Chinese People. Front Med (Lausanne). 2018; 5:50. PMC: 5863513. DOI: 10.3389/fmed.2018.00050. View

16.

Wang W, Chao C, Huang Y, Wang C, Chang C, Huang T . The impact of acute kidney injury with temporary dialysis on the risk of fracture. J Bone Miner Res. 2013; 29(3):676-84. DOI: 10.1002/jbmr.2061. View

17.

Verghese J, Wang C, Xue X, Holtzer R . Self-reported difficulty in climbing up or down stairs in nondisabled elderly. Arch Phys Med Rehabil. 2008; 89(1):100-4. PMC: 2671033. DOI: 10.1016/j.apmr.2007.08.129. View

18.

Li Y, Zou Y, Wang S, Li J, Jing X, Yang M . A Pilot Study of the FRAIL Scale on Predicting Outcomes in Chinese Elderly People With Type 2 Diabetes. J Am Med Dir Assoc. 2015; 16(8):714.e7-714.e12. DOI: 10.1016/j.jamda.2015.05.019. View

19.

Li P, Wang J, Guo H . A long-term quality-of-care score for predicting the occurrence of macrovascular diseases in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2018; 139:72-80. DOI: 10.1016/j.diabres.2018.02.027. View

20.

Sergi G, Veronese N, Fontana L, De Rui M, Bolzetta F, Zambon S . Pre-frailty and risk of cardiovascular disease in elderly men and women: the Pro.V.A. study. J Am Coll Cardiol. 2015; 65(10):976-83. DOI: 10.1016/j.jacc.2014.12.040. View